Genomics & Informatics10.5808/gi.2020.18.4.e442020184e44Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19Subrata K. Biswas, Sonchita R. Mudi,,
Biochemical and Biophysical Research Communications10.1016/j.bbrc.2020.10.1092021538104-107The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine designDanielle C. Groves, Sarah L. Rowland-Jones, Adrienn Angyal,
10.21203/ Topology Geometrics for the generation of the RoccustyrnaTM molecule, a ligand targeting COVID-19-SARS-COV-2 SPIKE D614G binding sitesIoannis Grigoriadis,
10.21203/ Phases on Chern-Simons Topological Geometrics for the Generation of A Ligand Targeting COVID-19-SARS-COV-2 SPIKE D614G Binding Sites.Ioannis Grigoriadis,
10.26434/chemrxiv.128279662020HUMAN SARS CoV-2 SPIKE PROTEIN MUTATIONSLalitha Guruprasad
10.26434/chemrxiv.12827966.v12020HUMAN SARS CoV-2 SPIKE PROTEIN MUTATIONSLalitha Guruprasad
International Journal of Infectious Diseases10.1016/j.ijid.2020.05.071202096459-460Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality?Muthukrishnan Eaaswarkhanth, Ashraf Al Madhoun, Fahd Al-Mulla,
SARS-CoV-2 Spike Protein Convergent Evolution10.1007/978-3-030-87324-0_5202127-54Spike Protein Mutations Detected in Currently Circulating StrainsDaniele Focosi
10.21203/ substitution at the hinge region enhances the stability of trimeric SARS-CoV-2 spike proteinArangasamy Yazhini, Das Swayam Prakash Sidhanta, Narayanaswamy Sriniva,
10.26434/chemrxiv.118714022020Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 InterfaceMicholas Smith, Jeremy C. Smith